The Most Exciting New Advances in Managing COPD
The Global Initiative for Chronic Obstructive Lung Disease, or GOLD, is the world’s preeminent COPD research and advocacy organization. Founded in 1997 in collaboration with the U.S. National Institutes of Health and the World Health Organization, one of GOLD’s stated aims is to “improve prevention and treatment of this lung disease.” In its 2023 global strategy report, GOLD changed its definition of COPD—which many in the profession viewed as overdue. Specifically, the new definition emphasized the heterogeneity of COPD in terms of its underlying drivers and long-term disease course. [ti...
Source: TIME: Health - March 18, 2024 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized freelance Source Type: news

Medics told to ration life-saving 'bread-and-butter medicine' used to help asthma patients breathe amid UK-wide shortage
The UK-wide shortage of the liquid form of salbutamol, which keeps patients who cannot breathe without medical intervention alive, has hit NHS hospitals. (Source: the Mail online | Health)
Source: the Mail online | Health - March 15, 2024 Category: Consumer Health News Source Type: news

There Are Multiple Child Asthma Triggers in Dirty Air
THURSDAY, March 14, 2024 -- There ' s a toxic stew of chemicals in polluted air that can all trigger asthma attacks in kids, new research shows. Also, where a child lives -- for example, near factories or highways -- greatly influences how much... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 14, 2024 Category: General Medicine Source Type: news

Three Trials Examine Dupilumab in Moderate-to-Severe Asthma
(MedPage Today) -- Three abstracts evaluating dupilumab (Dupixent) for moderate-to-severe asthma were presented at the recent American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting: VESTIGE, a phase IV trial which evaluated... (Source: MedPage Today Allergy)
Source: MedPage Today Allergy - March 12, 2024 Category: Allergy & Immunology Source Type: news

Why You Suddenly Have Allergies
When Dr. Gailen Marshall was training to become a physician, he was taught that allergies were a kid thing. “Back in the day, the allergist’s office was full of children,” says Marshall, who is the president of the American College of Allergy, Asthma, and Immunology. “If you ever thought about doing allergy testing or allergy shots in someone older than 40, that’s because you were just a money-grubbing doctor.” A lot has changed since then. In 2021, about a quarter of U.S. adults reported seasonal allergies, compared to 19% of children. [time-brightcove not-tgx=”true”] ...
Source: TIME: Health - March 12, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news

Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in India
AstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca will retain the intellectual property rights to Symbicort and continue as the marketing authorization holder. Symbicort, a top-selling product globally for AstraZeneca, recorded sales of around $2.4 billion in 2023. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 11, 2024 Category: Pharmaceuticals Source Type: news

Scientists Discover Toxic Microplastics In Every Human Placenta Tested In Study
Authored by Naveen Athrappully via The Epoch Times (emphasis ours), Harmful microplastics have been found in human placenta, with some of them known to trigger asthma, damage the liver, cause cancer, and impair…#naveenathrappully #epochtimes #richardthompson #universityofplymouth #ben #matthewcampen #microplastic #placentas #microplastics (Source: Reuters: Health)
Source: Reuters: Health - March 9, 2024 Category: Consumer Health News Source Type: news

American Academy of Allergy, Asthma & Immunology, Feb. 23 to 26
The annual meeting of the American Academy of Allergy, Asthma& Immunology was held from Feb. 23 to 26 in Washington, D.C., drawing participants from around the world, including clinicians, academicians, allied health professionals, and others... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2024 Category: Pharmaceuticals Source Type: news

Poorly controlled asthma generates greenhouse gases equivalent to 124,000 UK homes
Poorly controlled asthma is contributing to more than 300,000 tons of greenhouse gas emissions in the UK every year, an analysis has suggested. Most of the carbon footprint comes from over-reliance on reliever inhalers, a study published in Thorax and carried out by Astra Zeneca found. Using health records of 236,506 people with asthma between 2008 and... Read moreThe post Poorly controlled asthma generates greenhouse gases equivalent to 124,000 UK homes appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - March 7, 2024 Category: Nursing Authors: Megan Ford Tags: Clinical Latest news Respiratory Source Type: news

Boehringer to Cap Out-of-pocket Inhaler Cost At $35 Per Month Boehringer to Cap Out-of-pocket Inhaler Cost At $35 Per Month
Boehringer Ingelheim will cap out-of-pocket costs for the company ' s inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, the German...Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 7, 2024 Category: Consumer Health News Tags: Pulmonary Medicine Source Type: news

AAAAI: Early-Life Day Care Attendance May Lower Risk for Asthma, Allergies
WEDNESDAY, March 6, 2024 -- Early-life day care attendance may be protective against allergen sensitization, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma& Immunology, held from Feb. 23 to 26 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2024 Category: Pharmaceuticals Source Type: news

AAAAI: Nasal Delivery of Epinephrine Safe, Effective for Anaphylaxis
WEDNESDAY, March 6, 2024 -- Nasal powder formulations of epinephrine are effective and show superior stability to EpiPens, according to a study presented at the annual meeting of the American Academy of Allergy, Asthma& Immunology, held from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 6, 2024 Category: Pharmaceuticals Source Type: news

Dirty Air Increasingly Affects Minority Communities
WEDNESDAY, March 6, 2024 -- Air pollution harms the health of everyone exposed to it, but a new study says communities of color are disproportionately harmed by dirty air. Smog causes nearly 8 times higher childhood asthma rates and 1.3 times... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 6, 2024 Category: General Medicine Source Type: news

asthma & amp; allergy friendly ® Certification Program Honors Clients for Commitment to Innovation
The asthma & allergy friendly® Certification Program, which helps consumers identify products more suitable for people with asthma and allergies, has recognized the dedication and innovation of several of the Program's CERTIFIED clients. WASHINGTON, March 6, 2024 /PRNewswire-PRWeb/ -- The... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 6, 2024 Category: Pharmaceuticals Tags: AWD Source Type: news

Asthma Drug Xolair Now Indicated For Food Allergies: Next Challenge Is Insurer Coverage
Given the high price of Xolair and its need to be used indefinitely it can be a challenge to convince insurers to cover it in its new food allergy indication. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - March 5, 2024 Category: Pharmaceuticals Authors: Joshua Cohen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma & standard Source Type: news